Compliance Effect on the Flow Condition in Vascular In Vitro Experiments

Author(s):  
Masami Matsuura ◽  
Simon Tupin ◽  
Makoto Ohta

Endovascular treatment has become the standard for intracranial aneurysm management. In vitro systems including an artery model are required for devices evaluation and clinician training. Although silicone is usually use for such model, its compliance is known to be lower than blood vessels. The purpose of this study was to analyze the influence of model material compliance on flow properties. Silicone and 12 [wt%] poly (vinyl alcohol) hydrogel (PVA-H) were used to create two box-shaped models of significantly different compliance. The inner lumen geometry was a 4 [mm] diameter straight tube (parent vessel) and a 10 [mm] diameter sphere representing the aneurysm. A blood-mimicking fluid made of a mixture of glycerin, water and sodium iodide was used to reproduce the viscosity and density of blood and fit models refractive index. The circulation system consisted of a pulsatile blood pump and resistance valve. A flow rate of 250±50 [ml/min] and pressure from 75 to 115 [mmHg] were set inside the model. Pressure and flow rate sensors were used to monitor flow conditions before and after the model. Particle image velocimetry (PIV) was performed to record the difference of flow patterns inside the aneurysm of both model using a Nd:YAG solid laser system and fluorescent particles. Results revealed a significant change of flow conditions due to model compliance. Attenuation of the flow rate pulse was recorded between the inlet and the outlet of the both model. This attenuation was 51% for PVA-H model. Moreover, a time lag between outlet pressure and outlet flow rate curves was recorded in both model. This time lag was longer with the PVA-H model, as this model exhibit a greater compliance. PIV experiments revealed significant changes of flow patterns and velocity inside the aneurysm. Because of its high compliance, PVA-H model walls moved under the pulsatile conditions. A change of flow direction and decrease of its velocity were observed near the proximal wall of the aneurysm, compared to the silicone model. Such differences might modify the stress on the wall of the aneurysm. To conclude, our experiments revealed that compliance has significant impacts on flow properties and should be taken into account for in vitro vascular model manufacturing.

1983 ◽  
Vol 105 (3) ◽  
pp. 275-282 ◽  
Author(s):  
S. G. Kang ◽  
J. M. Tarbell

The impedance (pressure drop/flow rate) of four curved artery models has been determined experimentally for steady and periodic flows simulating conditions in the aortic arch. Steady flow results indicate that very short entry lengths are required for flow development in curved artery models, and impedance is elevated above straight tube values by a factor of 3–4 for mean flow conditions in the aortic arch. Results for periodic flow with a nonzero mean show a significant elevation of mean flow impedance relative to values for steady flow at the mean flow rate—a factor of 2–3 for aortic arch flow conditions. The impedance of the first harmonic of periodic flows follows straight tube theory at high values of the unsteadiness parameter in agreement with available theory for curved tubes. The implications of the impedance measurements for wall shear stress in the aortic arch are discussed.


2021 ◽  
Vol 8 (8) ◽  
pp. 107
Author(s):  
Lilis Iskandar ◽  
Lucy DiSilvio ◽  
Jonathan Acheson ◽  
Sanjukta Deb

Despite considerable advances in biomaterials-based bone tissue engineering technologies, autografts remain the gold standard for rehabilitating critical-sized bone defects in the oral and maxillofacial (OMF) region. A majority of advanced synthetic bone substitutes (SBS’s) have not transcended the pre-clinical stage due to inferior clinical performance and translational barriers, which include low scalability, high cost, regulatory restrictions, limited advanced facilities and human resources. The aim of this study is to develop clinically viable alternatives to address the challenges of bone tissue regeneration in the OMF region by developing ‘dual network composites’ (DNC’s) of calcium metaphosphate (CMP)—poly(vinyl alcohol) (PVA)/alginate with osteogenic ions: calcium, zinc and strontium. To fabricate DNC’s, single network composites of PVA/CMP with 10% (w/v) gelatine particles as porogen were developed using two freeze–thawing cycles and subsequently interpenetrated by guluronate-dominant sodium alginate and chelated with calcium, zinc or strontium ions. Physicochemical, compressive, water uptake, thermal, morphological and in vitro biological properties of DNC’s were characterised. The results demonstrated elastic 3D porous scaffolds resembling a ‘spongy bone’ with fluid absorbing capacity, easily sculptable to fit anatomically complex bone defects, biocompatible and osteoconductive in vitro, thus yielding potentially clinically viable for SBS alternatives in OMF surgery.


2008 ◽  
Vol 53 (1) ◽  
pp. 157-161 ◽  
Author(s):  
Syed Hussain ◽  
Muhammad Malik ◽  
Lanbo Shi ◽  
Maria Laura Gennaro ◽  
Karl Drlica

ABSTRACT An in vitro model of mycobacterial growth arrest was developed using Mycobacterium bovis BCG. When an exponentially growing culture was transferred to an evacuated tube, growth continued; treatment with a source of nitric oxide (diethylenetriamine-nitric oxide adduct [DETA-NO] at 50 μM) halted growth immediately, and aeration restored growth. When the period of growth arrest exceeded 4 h, a time lag occurred before aeration could restore growth. The lag time was maximal (24 h) after 16 h of growth arrest. These time lags indicated that one transition period was required for cells to achieve full arrest of growth and another for them to recover fully from growth arrest. DETA-NO-induced growth arrest failed to protect from the lethal effects of anaerobic shock, which caused rapid lysis of both growing and growth-arrested cells. While growth arrest had little effect on the lethal action of rifampin, it eliminated isoniazid lethality. Growth arrest reduced but did not eliminate fluoroquinolone lethality. Two fluoroquinolones, moxifloxacin and gatifloxacin, were equally lethal to exponentially growing cells, but moxifloxacin was more active during growth arrest. This difference is attributed to the fluoroquinolone C-7 ring structure, the only difference between the compounds. Collectively these data characterize a new system for halting mycobacterial growth that may be useful for evaluating new antituberculosis agents.


Author(s):  
Christoph Bettag ◽  
Christian von der Brelie ◽  
Florian Baptist Freimann ◽  
Ulrich-Wilhelm Thomale ◽  
Veit Rohde ◽  
...  

AbstractDiagnosis of symptomatic valve malfunction in hydrocephalic patients treated with VP-Shunt (VPS) might be difficult. Clinical symptoms such as headache or nausea are nonspecific, hence cerebrospinal fluid (CSF) over- or underdrainage can only be suspected but not proven. Knowledge concerning valve malfunction is still limited. We aim to provide data on the flow characteristics of explanted shunt valves in patients with suspected valve malfunction. An in vitro shunt laboratory setup was used to analyze the explanted valves under conditions similar to those in an implanted VPS. The differential pressure (DP) of the valve was adjusted stepwise to 20, 10, 6, and 4 cmH2O. The flow rate of the explanted and the regular flow rate of an identical reference valve were evaluated at the respective DPs. Twelve valves of different types (Codman CertasPlus valve n = 3, Miethke Shuntassistant valve n = 4, Codman Hakim programmable valve n = 3, DP component of Miethke proGAV 2.0 valve n = 2) from eight hydrocephalic patients (four male), in whom valve malfunction was assumed between 2016 and 2017, were replaced with a new valve. Four patients suffered from idiopathic normal pressure (iNPH), three patients from malresorptive and one patient from obstructive hydrocephalus. Post-hoc analysis revealed a significant difference (p < 0.001) of the flow rate between each explanted valve and their corresponding reference valve, at each DP. In all patients, significant alterations of flow rates were demonstrated, verifying a valve malfunction, which could not be objectified by the diagnostic tools used in the clinical routine. In cases with obscure clinical VPS insufficiency, valve deficiency should be considered.


2021 ◽  
Vol 2 (1) ◽  
pp. 61-77
Author(s):  
Hamid Reza Jafari ◽  
Ali Davoodi ◽  
Saman Hosseinpour

In this work, the corrosion behavior and surface reactivity of as-cast and heat-treated nickel aluminum bronze casting alloy (UNS C95800) in 3.5 wt% NaCl solution is investigated under stagnant and flow conditions. Increasing flow rate conditions are simulated using a rotating disk electrode from 0 to 9000 revolutions per minute (rpm). Optical micrographs confirm the decrease in the phase fraction of corrosion-sensitive β phase in the microstructure of C95800 after annealing, which, in turn, enhances the corrosion resistance of the alloy. Electrochemical studies including open circuit potentiometry, potentiodynamic polarization, and electrochemical impedance spectroscopy are performed to assess the effect of flow rate and heat treatment on the corrosion of samples at 25 and 40 °C in 3.5 wt% NaCl solution. For both as-cast and heat-treated samples, increasing the flow rate (i.e., electrode rotating rate) linearly reduces the corrosion resistance, indicating that the metal dissolution rate is significantly affected by hydrodynamic flow. Increasing the solution temperature negatively impacts the corrosion behavior of the as-cast and heat-treated samples at all flow conditions.


2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Tobias Blanke ◽  
Markus Hagenkamp ◽  
Bernd Döring ◽  
Joachim Göttsche ◽  
Vitali Reger ◽  
...  

AbstractPrevious studies optimized the dimensions of coaxial heat exchangers using constant mass flow rates as a boundary condition. They show a thermal optimal circular ring width of nearly zero. Hydraulically optimal is an inner to outer pipe radius ratio of 0.65 for turbulent and 0.68 for laminar flow types. In contrast, in this study, flow conditions in the circular ring are kept constant (a set of fixed Reynolds numbers) during optimization. This approach ensures fixed flow conditions and prevents inappropriately high or low mass flow rates. The optimization is carried out for three objectives: Maximum energy gain, minimum hydraulic effort and eventually optimum net-exergy balance. The optimization changes the inner pipe radius and mass flow rate but not the Reynolds number of the circular ring. The thermal calculations base on Hellström’s borehole resistance and the hydraulic optimization on individually calculated linear loss of head coefficients. Increasing the inner pipe radius results in decreased hydraulic losses in the inner pipe but increased losses in the circular ring. The net-exergy difference is a key performance indicator and combines thermal and hydraulic calculations. It is the difference between thermal exergy flux and hydraulic effort. The Reynolds number in the circular ring is instead of the mass flow rate constant during all optimizations. The result from a thermal perspective is an optimal width of the circular ring of nearly zero. The hydraulically optimal inner pipe radius is 54% of the outer pipe radius for laminar flow and 60% for turbulent flow scenarios. Net-exergetic optimization shows a predominant influence of hydraulic losses, especially for small temperature gains. The exact result depends on the earth’s thermal properties and the flow type. Conclusively, coaxial geothermal probes’ design should focus on the hydraulic optimum and take the thermal optimum as a secondary criterion due to the dominating hydraulics.


Pharmaceutics ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 1207
Author(s):  
Andrea Vítečková Wünschová ◽  
Adam Novobilský ◽  
Jana Hložková ◽  
Peter Scheer ◽  
Hana Petroková ◽  
...  

Diseases with the highest burden for society such as stroke, myocardial infarction, pulmonary embolism, and others are due to blood clots. Preclinical and clinical techniques to study blood clots are important tools for translational research of new diagnostic and therapeutic modalities that target blood clots. In this study, we employed a three-dimensional (3D) printed middle cerebral artery model to image clots under flow conditions using preclinical imaging techniques including fluorescent whole-body imaging, magnetic resonance imaging (MRI), and computed X-ray microtomography (microCT). Both liposome-based, fibrin-targeted, and non-targeted contrast agents were proven to provide a sufficient signal for clot imaging within the model under flow conditions. The application of the model for clot targeting studies and thrombolytic studies using preclinical imaging techniques is shown here. For the first time, a novel method of thrombus labeling utilizing barium sulphate (Micropaque®) is presented here as an example of successfully employed contrast agents for in vitro experiments evaluating the time-course of thrombolysis and thus the efficacy of a thrombolytic drug, recombinant tissue plasminogen activator (rtPA). Finally, the proof-of-concept of in vivo clot imaging in a middle cerebral artery occlusion (MCAO) rat model using barium sulphate-labelled clots is presented, confirming the great potential of such an approach to make experiments comparable between in vitro and in vivo models, finally leading to a reduction in animals needed.


2019 ◽  
Vol 20 (20) ◽  
pp. 5126 ◽  
Author(s):  
Caterina Cristallini ◽  
Serena Danti ◽  
Bahareh Azimi ◽  
Veronika Tempesti ◽  
Claudio Ricci ◽  
...  

The objective of this study was the preparation and physico-chemical, mechanical, biological, and functional characterization of a multifunctional coating for an innovative, fully implantable device. The multifunctional coating was designed to have three fundamental properties: adhesion to device, close mechanical resemblance to human soft tissues, and control of the inflammatory response and tissue repair process. This aim was fulfilled by preparing a multilayered coating based on three components: a hydrophilic primer to allow device adhesion, a poly(vinyl alcohol) hydrogel layer to provide good mechanical compliance with the human tissue, and a layer of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fibers. The use of biopolymer fibers offered the potential for a long-term interface able to modulate the release of an anti-inflammatory drug (dexamethasone), thus contrasting acute and chronic inflammation response following device implantation. Two copolymers, poly(vinyl acetate-acrylic acid) and poly(vinyl alcohol-acrylic acid), were synthetized and characterized using thermal analysis (DSC, TGA), Fourier transform infrared spectroscopy (FT-IR chemical imaging), in vitro cell viability, and an adhesion test. The resulting hydrogels were biocompatible, biostable, mechanically compatible with soft tissues, and able to incorporate and release the drug. Finally, the multifunctional coating showed a good adhesion to titanium substrate, no in vitro cytotoxicity, and a prolonged and controlled drug release.


2019 ◽  
Vol 829 ◽  
pp. 263-269
Author(s):  
Denny Nurdin ◽  
Andri Hardiansyah ◽  
Elsy Rahimi Chaldun ◽  
Anti Khoerul Fikkriyah ◽  
Hendra Dian Adhita Dharsono ◽  
...  

Exploration of natural compound for the treatment of dental-related problems are gaining of interest for enhancing therapeutic efficacy of the drugs delivery system. In this study, we have prepared terpenoid, which have been isolated from Myrmecodia pendens Merr & Perry from Papua Island, Indonesia, to be encapsulated in Polylactic-co-glycolic acid (PLGA), as the most widely used biodegradable polymer for biomedical applications, through one step single-emulsion method followed by subsequent coating by poly (vinyl alcohol) (PVA). The resultant of terpenoid-loaded PLGA microparticles were characterized systematically through scanning electron microscope and Fourier-transform infrared spectroscopy. In vitro drug release test was evaluated through dialysis method. Antibacterial test was conducted against Enterococcus faecalis as a model for persistent bacteria that causes root canal infections. The results showed that terpenoid-loaded PLGA microparticles were developed in spherical morphology with an average particle size of around 1-2μm. Terpenoid released from PLGA compartment at pH 6.5 and temperature of 37°C through a controlled-release profile mechanism with enhanced prolonged release. The bacterial assay result showed that terpenoid-loaded PLGA microparticles could reduce Enterococcus faecalis, effectively. Eventually, these result show that terpenoid-loaded PLGA microparticles as unique natural product-based extract could be developed as a potential naturally-based drug for dental-related diseases applications.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Lauren Andrews ◽  
Scott Benken ◽  
Xing Tan ◽  
Eric Wenzler

Abstract Background To evaluate the transmembrane clearance (CLTM) of apixaban during modeled in vitro continuous renal replacement therapy (CRRT), assess protein binding and circuit adsorption, and provide initial dosing recommendations. Methods Apixaban was added to the CRRT circuit and serial pre-filter bovine blood samples were collected along with post-filter blood and effluent samples. All experiments were performed in duplicate using continuous veno-venous hemofiltration (CVVH) and hemodialysis (CVVHD) modes, with varying filter types, flow rates, and point of CVVH replacement fluid dilution. Concentrations of apixaban and urea were quantified via liquid chromatography-tandem mass spectrometry. Plasma pharmacokinetic parameters for apixaban were estimated via noncompartmental analysis. CLTM was calculated via the estimated area under the curve (AUC) and by the product of the sieving/saturation coefficient (SC/SA) and flow rate. Two and three-way analysis of variance (ANOVA) models were built to assess the effects of mode, filter type, flow rate, and point of dilution on CLTM by each method. Optimal doses were suggested by matching the AUC observed in vitro to the systemic exposure demonstrated in Phase 2/3 studies of apixaban. Linear regression was utilized to provide dosing estimations for flow rates from 0.5–5 L/h. Results Mean adsorption to the HF1400 and M150 filters differed significantly at 38 and 13%, respectively, while mean (± standard deviation, SD) percent protein binding was 70.81 ± 0.01%. Effect of CVVH point of dilution did not differ across filter types, although CLTM was consistently significantly higher during CRRT with the HF1400 filter compared to the M150. The three-way ANOVA demonstrated improved fit when CLTM values calculated by AUC were used (adjusted R2 0.87 vs. 0.52), and therefore, these values were used to generate optimal dosing recommendations. Linear regression revealed significant effects of filter type and flow rate on CLTM by AUC, suggesting doses of 2.5–7.5 mg twice daily (BID) may be needed for flow rates ranging from 0.5–5 L/h, respectively. Conclusion For CRRT flow rates most commonly employed in clinical practice, the standard labeled 5 mg BID dose of apixaban is predicted to achieve target systemic exposure thresholds. The safety and efficacy of these proposed dosing regimens warrants further investigation in clinical studies.


Sign in / Sign up

Export Citation Format

Share Document